Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
50% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7.6K |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$7.6K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $9.8M | $5.4M | $4.1M | $5.7M | $8.5M | $13.5M | $14.8M | $8.7M |
| Operating income | −$12.1M | −$7.0M | −$5.0M | −$7.6M | −$10.8M | −$16.9M | −$21.5M | −$13.4M |
| EBITDA | −$12.0M | −$6.9M | −$6.0M | −$7.3M | −$14.4M | −$16.9M | −$21.4M | −$13.4M |
| Net income | −$12.9M | −$6.9M | −$4.0M | −$8.2M | −$20.7M | −$58.2M | $7.8M | −$11.5M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -6.45 | -2.72 | -1.58 | -1.90 | -4.57 | -7.75 | 0.31 | -0.57 |
Annual figures · source: Financial Modeling Prep
ARNO THERAPEUTICS INC
No one on the platform currently holds ARNI.
No tracked institution reports a position in ARNI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2013-10-30 | 1-for-8reverse |
No one on the platform has traded ARNI yet.
| $1949 |
| — |
| IVBTInnovation1 Biotech Inc. | $0.00 | +0.00% | $4494 | — |
| KLDOKaleido Biosciences, Inc. | $0.00 | +0.00% | $4262 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.